Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$87.34 1.27 (1.43%) as of 4:30 Thu 3/28


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.45(B)
Last Volume: 1,027,708 Avg Vol: 1,398,626
52 Week Range: $76.22 - $100.3
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 92,341 116,105 269,465 610,463
Total Sell Value $8,237,699 $10,489,308 $24,880,826 $57,517,351
Total People Sold 3 4 5 8
Total Sell Transactions 9 11 22 59
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 1281
  Page 10 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mueller Brian VP, Corporate Controller   •       –      –    2013-05-08 4 D $65.32 $31,288 D/D (479) 8,924     -
   Davis George Eric SVP, General Counsel   •       –      –    2013-05-08 4 D $65.32 $108,692 D/D (1,664) 45,394     -
   Ajer Jeffrey Robert SVP, Chief Commercial Of   •       –      –    2013-05-08 4 D $65.32 $31,941 D/D (489) 10,081     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-05-08 4 D $65.32 $136,388 D/D (2,088) 50,262     -
   Fuchs Henry J EVP, Chief Medical Officer   •       –      –    2013-05-08 4 D $65.32 $204,517 D/D (3,131) 42,374     -
   Wood Mark VP, Human Resources   •       –      –    2013-05-08 4 D $65.32 $85,243 D/D (1,305) 22,535     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-08 4 GD $0.00 $0 D/D 1,000 111,838     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-08 4 D $65.32 $357,888 D/D (5,479) 112,838     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-08 4 AS $65.88 $65,879 D/D (1,000) 118,317     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-07 4 AS $65.87 $197,613 I/I (3,000) 13,545     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-07 4 OE $12.99 $38,970 I/I 3,000 16,545     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-03 4 AS $67.21 $537,950 I/I (8,000) 13,545     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-03 4 OE $12.99 $103,920 I/I 8,000 18,545     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-05-03 4 AS $67.00 $1,340,000 D/D (20,000) 53,155     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-05-03 4 OE $14.39 $287,800 D/D 20,000 73,155     -
   Davis George Eric SVP, General Counsel   •       –      –    2013-05-03 4 S $67.19 $393,327 D/D (5,854) 47,058     -
   Davis George Eric SVP, General Counsel   •       –      –    2013-05-03 4 OE $14.39 $95,459 D/D 5,854 52,912     -
   Mueller Brian VP, Corporate Controller   •       –      –    2013-05-03 4 S $67.11 $503,295 D/D (7,500) 9,403     -
   Mueller Brian VP, Corporate Controller   •       –      –    2013-05-03 4 OE $21.51 $161,325 D/D 7,500 16,903     -
   Mueller Brian VP, Corporate Controller   •       –      –    2013-05-02 4 S $65.35 $610,354 D/D (9,331) 9,403     -
   Mueller Brian VP, Corporate Controller   •       –      –    2013-05-02 4 OE $14.39 $70,137 D/D 4,874 18,734     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-02 4 S $65.62 $131,241 I/I (2,000) 13,545     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2013-05-02 4 OE $12.99 $25,980 I/I 2,000 15,545     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-05-01 4 GA $0.00 $0 I/I 805 9,043     -
   Baffi Robert EVP, Technical Operations   •       –      –    2013-05-01 4 GD $0.00 $0 D/D 805 52,350     -

  1281 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed